1004-P: Oral Semaglutide vs. Placebo in Patients With Type 2 Diabetes and Moderate Renal Impairment: PIONEER 5
Diabetes - United States
doi 10.2337/db19-1004-p
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2019
Authors
Publisher
American Diabetes Association